US Dermatology OTC Medications Market
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin related diseases, such as pigmentation, acne, wrinkles, and psoriasis. OTC drugs are medications that are safe and effective for use by the public without seeking treatment by a health professional. The US dermatology OTC medications market growth is mainly attributed to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). Moreover, growing OTC market is further expected to foster the market growth during the forecast period. However, the side effects associated with OTC dermatology medication such as skin allergy, limit the growth of the market.
COVID-19 has affected a large population in the US leading to an unprecedented surge in demand for popular OTC drugs. Consumers appear to be trying to address illness symptoms on their own, to avoid doctor’s office. Physical distancing and stay-at-home orders have forced consumer to shop differently. Also, continuous use of mask and constant handwashing has led to skin irritation, and maskne. Constant handwashing has led to increase in conditions like skin dryness and eczema, this has led to increase in demand for dermatology OTC products.
Strategic insights for the US Dermatology OTC Medications provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 952.97 Million |
| Market Size by 2028 | US$ 1,124.56 Million |
| Global CAGR (2021 - 2028) | 2.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | United States
|
| Market leaders and key company profiles |
The geographic scope of the US Dermatology OTC Medications refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The US dermatology OTC medications market is projected to reach US$ 1,124.56 million by 2028 from US$ 952.97 million in 2020. The market is anticipated to grow with a CAGR of 2.1% from 2021 to 2028. Factors driving the market growth are rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). However, side effects associated with OTC dermatology medication such as skin allergy are likely to have a negative impact on the market growth.
Based on product type, the creams and ointments segment accounted for the largest share of the US dermatology OTC medications market in 2020. In terms of indication, the dermatitis segment held the largest share of the dermatology OTC medications market in the US. Based on route of administration, the topical segment held a larger share of the dermatology OTC medications market in the US. Based on distribution channel, the hospital and retail pharmacies segment held the largest share of the market.
A few major primary and secondary sources referred to while preparing the US dermatology OTC medications market report are World Health Organization, and Centre for Disease Prevention and Control.
US DERMATOLOGY OTC MEDICATIONSMARKET SEGMENTATION
By Product Type
By Indication
By Route of Administration
By Distribution Channel
Company Profiles
The List of Companies - US Dermatology OTC Medications Market
The US Dermatology OTC Medications Market is valued at US$ 952.97 Million in 2020, it is projected to reach US$ 1,124.56 Million by 2028.
As per our report US Dermatology OTC Medications Market, the market size is valued at US$ 952.97 Million in 2020, projecting it to reach US$ 1,124.56 Million by 2028. This translates to a CAGR of approximately 2.1% during the forecast period.
The US Dermatology OTC Medications Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Dermatology OTC Medications Market report:
The US Dermatology OTC Medications Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Dermatology OTC Medications Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Dermatology OTC Medications Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For US Dermatology OTC Medications Market
